Virologica Sinica

, Volume 29, Issue 2, pp 74–85 | Cite as

Functional interplay among the flavivirus NS3 protease, helicase, and cofactors

Review

Abstract

Flaviviruses are positive-sense RNA viruses, and many are important human pathogens. Nonstructural protein 2B and 3 of the flaviviruses (NS2BNS3) form an endoplasmic reticulum (ER) membrane-associated hetero-dimeric complex through the NS2B transmembrane region. The NS2BNS3 complex is multifunctional. The N-terminal region of NS3, and its cofactor NS2B fold into a protease that is responsible for viral polyprotein processing, and the C-terminal domain of NS3 possesses NTPase/RNA helicase activities and is involved in viral RNA replication and virus particle formation. In addition, NS2BNS3 complex has also been shown to modulate viral pathogenesis and the host immune response. Because of the essential functions that the NS2BNS3 complex plays in the flavivirus life cycle, it is an attractive target for antiviral development. This review focuses on the recent biochemical and structural advances of NS2BNS3 and provides a brief update on the current status of drug development targeting this viral protein complex.

Keywords

crystal structures antiviral drug target serine protease RNA helicase 

References

  1. Aguirre S, Maestre A M, Pagni S, Patel J R, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman R S, Simon V, Rodriguez-Madoz J R, Mulder L C, Barber G N, Fernandez-Sesma A. 2012. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog, 8: e1002934.PubMedCentralPubMedGoogle Scholar
  2. Aleshin A E, Shiryaev S A, Strongin A Y, Liddington R C. 2007. Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci, 16: 795–806.PubMedCentralPubMedGoogle Scholar
  3. Alvarez D E, Lodeiro M F, Filomatori C V, Fucito S, Mondotte J A, Gamarnik A V. 2006. Structural and functional analysis of dengue virus RNA. Novartis Found Symp, 277: 120–132; discussion 132–125, 251–123.PubMedGoogle Scholar
  4. Appleby T C, Anderson R, Fedorova O, Pyle A M, Wang R, Liu X, Brendza K M, Somoza J R. 2010. Visualizing ATP-dependent RNA translocation by the NS3 helicase from HCV. J Mol Biol, 405: 1139–1153.PubMedCentralPubMedGoogle Scholar
  5. Arakaki T L, Fang N X, Fairlie D P, Young P R, Martin J L. 2002. Catalytically active Dengue virus NS3 protease forms aggregates that are separable by size exclusion chromatography. Protein Expr Purif, 25: 241–247.PubMedGoogle Scholar
  6. Assenberg R, Mastrangelo E, Walter T S, Verma A, Milani M, Owens R J, Stuart D I, Grimes J M, Mancini E J. 2009. Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol, 83: 12895–12906.PubMedCentralPubMedGoogle Scholar
  7. Balistreri G, Caldentey J, Kaariainen L, Ahola T. 2007. Enzymatic defects of the nsP2 proteins of Semliki Forest virus temperature-sensitive mutants. J Virol, 81: 2849–2860.PubMedCentralPubMedGoogle Scholar
  8. Benarroch D, Selisko B, Locatelli G A, Maga G, Romette J L, Canard B. 2004. The RNA helicase, nucleotide 5′-triphosphatase, and RNA 5′-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core. Virology, 328: 208–218.PubMedGoogle Scholar
  9. Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould E A, Grard G, Grimes J M, Hilgenfeld R, Jansson A M, Malet H, Mancini E J, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens R J, Ren J, Selisko B, Speroni S, Steuber H, Stuart D I, Unge T, Bolognesi M. 2010. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res, 87: 125–148.PubMedCentralPubMedGoogle Scholar
  10. Brooks A J, Johansson M, John A V, Xu Y, Jans D A, Vasudevan S G. 2002. The interdomain region of dengue NS5 protein that binds to the viral helicase NS3 contains independently functional importin beta 1 and importin alpha/beta-recognized nuclear localization signals. J Biol Chem, 277: 36399–36407.PubMedGoogle Scholar
  11. Buttner K, Nehring S, Hopfner K P. 2007. Structural basis for DNA duplex separation by a superfamily-2 helicase. Nat Struct Mol Biol, 14: 647–652.PubMedGoogle Scholar
  12. Byrd C M, Grosenbach D W, Berhanu A, Dai D, Jones K F, Cardwell K B, Schneider C, Yang G, Tyavanagimatt S, Harver C, Wineinger K A, Page J, Stavale E, Stone M A, Fuller K P, Lovejoy C, Leeds J M, Hruby D E, Jordan R. 2013. Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrob Agents Chemother, 57: 1902–1912.PubMedCentralPubMedGoogle Scholar
  13. Chambers T J, Hahn C S, Galler R, Rice C M. 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol, 44: 649–688.PubMedGoogle Scholar
  14. Chandramouli S, Joseph J S, Daudenarde S, Gatchalian J, Cornillez-Ty C, Kuhn P. 2010. Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family. J Virol, 84: 3059–3067.PubMedCentralPubMedGoogle Scholar
  15. Chappell K J, Stoermer M J, Fairlie D P, Young P R. 2008. Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity. J Gen Virol, 89: 1010–1014.PubMedGoogle Scholar
  16. Chernov A V, Shiryaev S A, Aleshin A E, Ratnikov B I, Smith J W, Liddington R C, Strongin A Y. 2008. The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase. J Biol Chem, 283: 17270–17278.PubMedCentralPubMedGoogle Scholar
  17. Choksupmanee O, Hodge K, Katzenmeier G, Chimnaronk S. 2012. Structural platform for the autolytic activity of an intact NS2B-NS3 protease complex from dengue virus. Biochemistry, 51: 2840–2851.PubMedGoogle Scholar
  18. Clum S, Ebner K E, Padmanabhan R. 1997. Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B. J Biol Chem, 272: 30715–30723.PubMedGoogle Scholar
  19. Decroly E, Ferron F, Lescar J, Canard B. 2012. Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol, 10: 51–65.Google Scholar
  20. Dumont S, Cheng W, Serebrov V, Beran R K, Tinoco I, Jr., Pyle A M, Bustamante C. 2006. RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature, 439: 105–108.PubMedCentralPubMedGoogle Scholar
  21. Egloff M P, Benarroch D, Selisko B, Romette J L, Canard B. 2002. An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J, 21: 2757–2768.PubMedCentralPubMedGoogle Scholar
  22. Erbel P, Schiering N, D’Arcy A, Renatus M, Kroemer M, Lim S P, Yin Z, Keller T H, Vasudevan S G, Hommel U. 2006. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol, 13: 372–373.PubMedGoogle Scholar
  23. Fairman-Williams M E, Guenther U P, Jankowsky E. 2010. SF1 and SF2 helicases: family matters. Curr Opin Struct Biol, 20: 313–324.PubMedCentralPubMedGoogle Scholar
  24. Falgout B, Pethel M, Zhang Y M, Lai C J. 1991. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol, 65: 2467–2475.PubMedCentralPubMedGoogle Scholar
  25. Filomatori C V, Lodeiro M F, Alvarez D E, Samsa M M, Pietrasanta L, Gamarnik A V. 2006. A 5′ RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev, 20: 2238–2249.PubMedCentralPubMedGoogle Scholar
  26. Frick D N, Rypma R S, Lam A M, Gu B. 2004. The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. J Biol Chem, 279: 1269–1280.PubMedCentralPubMedGoogle Scholar
  27. Gebhard L G, Kaufman S B, Gamarnik A V. 2012. Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase. PLoS One, 7: e36244.PubMedCentralPubMedGoogle Scholar
  28. Gorbalenya A E, Koonin E V. 1993. Helicases: amino acid sequence comparisons and structure-function relationships. Curr Opin Struc Biol, 3: 419–429.Google Scholar
  29. Gorbalenya A E, Donchenko A P, Koonin E V, Blinov V M. 1989. N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res, 17: 3889–3897.PubMedCentralPubMedGoogle Scholar
  30. Gouvea I E, Izidoro M A, Judice W A, Cezari M H, Caliendo G, Santagada V, dos Santos C N, Queiroz M H, Juliano M A, Young P R, Fairlie D P, Juliano L. 2007. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates. Arch Biochem Biophys, 457: 187–196.PubMedGoogle Scholar
  31. Gu M, Rice C M. 2010. Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism. Proc Natl Acad Sci USA, 107: 521–528.PubMedCentralPubMedGoogle Scholar
  32. Huang Q, Li Q, Joy J, Chen A S, Ruiz-Carrillo D, Hill J, Lescar J, Kang C. 2013. Lyso-myristoyl phosphatidylcholine micelles sustain the activity of Dengue non-structural (NS) protein 3 protease domain fused with the full-length NS2B. Protein Expr Purif, 92: 156–162.PubMedGoogle Scholar
  33. Ishikawa H, Barber G N. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature, 455: 674–678.PubMedCentralPubMedGoogle Scholar
  34. Jan L R, Yang C S, Trent D W, Falgout B, Lai C J. 1995. Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases. J Gen Virol, 76: 573–580.PubMedGoogle Scholar
  35. Keller T H, Chen Y L, Knox J E, Lim S P, Ma N L, Patel S J, Sampath A, Wang Q Y, Yin Z, Vasudevan S G. 2006. Finding new medicines for flaviviral targets. Novartis Found Symp, 277: 102–114; discussion 114–109, 251–103.PubMedGoogle Scholar
  36. Khadka S, Vangeloff A D, Zhang C, Siddavatam P, Heaton N S, Wang L, Sengupta R, Sahasrabudhe S, Randall G, Gribskov M, Kuhn R J, Perera R, LaCount D J. 2011. A physical interaction network of dengue virus and human proteins. Mol Cell Proteomics, 10: M111 012187.PubMedCentralPubMedGoogle Scholar
  37. Kim J L, Morgenstern K A, Lin C, Fox T, Dwyer M D, Landro J A, Chambers S P, Markland W, Lepre C A, O’Malley E T, Harbeson S L, Rice C M, Murcko M A, Caron P R, Thomson J A. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell, 87: 343–355.PubMedGoogle Scholar
  38. Krishnan M N, Garcia-Blanco M A. 2014. Targeting host factors to treat west nile and dengue viral infections. Viruses, 6: 683–708.PubMedCentralPubMedGoogle Scholar
  39. Le Breton M, Meyniel-Schicklin L, Deloire A, Coutard B, Canard B, de Lamballerie X, Andre P, Rabourdin-Combe C, Lotteau V, Davoust N. 2011. Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen. BMC Microbiol, 11: 234.PubMedCentralPubMedGoogle Scholar
  40. Lescar J, Luo D, Xu T, Sampath A, Lim S P, Canard B, Vasudevan S G. 2008. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res, 80: 94–101.PubMedGoogle Scholar
  41. Leung D, Schroder K, White H, Fang N X, Stoermer M J, Abbenante G, Martin J L, Young P R, Fairlie D P. 2001. Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem, 276: 45762–45771.PubMedGoogle Scholar
  42. Li H, Clum S, You S, Ebner K E, Padmanabhan R. 1999. The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol, 73: 3108–3116.PubMedCentralPubMedGoogle Scholar
  43. Li J, Lim S P, Beer D, Patel V, Wen D, Tumanut C, Tully D C, Williams J A, Jiricek J, Priestle J P, Harris J L, Vasudevan S G. 2005. Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem, 280: 28766–28774.PubMedGoogle Scholar
  44. Li K, Frankowski K J, Hanson A M, Ndjomou J, Shanahan M A, Mukherjee S, Kolli R, Shadrick W R, Sweeney N L, Belon C A, Neuenswander B, Ferguson J, Aubé J, Schoenen F J, Blagg B S J, Frick D N. 2010. Hepatitis C Virus NS3 Helicase Inhibitor Discovery. In: Probe Reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information, Bethesda (MD).Google Scholar
  45. Lim S P, Wang Q Y, Noble C G, Chen Y L, Dong H, Zou B, Yokokawa F, Nilar S, Smith P, Beer D, Lescar J, Shi P Y. 2013. Ten years of dengue drug discovery: progress and prospects. Antiviral Res, 100: 500–519.PubMedGoogle Scholar
  46. Lin C W, Lin K H, Lyu P C, Chen W J. 2006. Japanese encephalitis virus NS2B-NS3 protease binding to phage-displayed human brain proteins with the domain of trypsin inhibitor and basic region leucine zipper. Virus Res, 116: 106–113.PubMedGoogle Scholar
  47. Lindenbach B D, Thiel H J, Rice C M. 2007. Flaviviridae: the viruses and their replication. In: Knipe D M, Howley P M. Eds. Lippincott-Raven Publishers, Philadelphia. pp1101–1152.Google Scholar
  48. Linder P, Jankowsky E. 2011. From unwinding to clamping — the DEAD box RNA helicase family. Nat Rev Mol Cell Biol, 12: 505–516.PubMedGoogle Scholar
  49. Luo D, Lim S P, Lescar J. 2012. The Flavivirus NS3 Protein: Structure and Functions. In: Shi P Y. Eds. Molecular Virology and Control of Flaviviruses. Caister Academic Press, Norfolk. pp77–100.Google Scholar
  50. Luo D, Xu T, Hunke C, Gruber G, Vasudevan S G, Lescar J. 2008. Crystal structure of the NS3 protease-helicase from dengue virus. J Virol, 82: 173–183.PubMedCentralPubMedGoogle Scholar
  51. Luo D, Wei N, Doan D N, Paradkar P N, Chong Y, Davidson A D, Kotaka M, Lescar J, Vasudevan S G. 2010. Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implications. J Biol Chem, 285: 18817–18827.PubMedCentralPubMedGoogle Scholar
  52. Luo D, Xu T, Watson R P, Scherer-Becker D, Sampath A, Jahnke W, Yeong S S, Wang C H, Lim S P, Strongin A, Vasudevan S G, Lescar J. 2008. Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J, 27: 3209–3219.PubMedCentralPubMedGoogle Scholar
  53. Mackenzie J. 2005. Wrapping things up about virus RNA replication. Traffic, 6: 967–977.PubMedGoogle Scholar
  54. Maga G, Gemma S, Fattorusso C, Locatelli G A, Butini S, Persico M, Kukreja G, Romano M P, Chiasserini L, Savini L, Novellino E, Nacci V, Spadari S, Campiani G. 2005. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663. Biochemistry, 44: 9637–9644.PubMedGoogle Scholar
  55. Malet H, Masse N, Selisko B, Romette J L, Alvarez K, Guillemot J C, Tolou H, Yap T L, Vasudevan S, Lescar J, Canard B. 2008. The flavivirus polymerase as a target for drug discovery. Antiviral Res, 80: 23–35.PubMedGoogle Scholar
  56. Malet H, Egloff M P, Selisko B, Butcher R E, Wright P J, Roberts M, Gruez A, Sulzenbacher G, Vonrhein C, Bricogne G, Mackenzie J M, Khromykh A A, Davidson A D, Canard B. 2007. Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5. J Biol Chem, 282: 10678–10689.PubMedGoogle Scholar
  57. Mancini E J, Assenberg R, Verma A, Walter T S, Tuma R, Grimes J M, Owens R J, Stuart D I. 2007. Structure of the Murray Valley encephalitis virus RNA helicase at 1.9 Angstrom resolution. Protein Sci, 16: 2294–2300.PubMedCentralPubMedGoogle Scholar
  58. Markoff L. 2003. 5′- and 3′-noncoding regions in flavivirus RNA. Adv Virus Res, 59: 177–228.PubMedGoogle Scholar
  59. Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson A M, Frick D N, Bolognesi M, Milani M. 2012. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother, 67: 1884–1894.PubMedCentralPubMedGoogle Scholar
  60. Mastrangelo E, Milani M, Bollati M, Selisko B, Peyrane F, Pandini V, Sorrentino G, Canard B, Konarev P V, Svergun D I, de Lamballerie X, Coutard B, Khromykh A A, Bolognesi M. 2007. Crystal structure and activity of Kunjin virus NS3 helicase; protease and helicase domain assembly in the full length NS3 protein. J Mol Biol, 372: 444–455.PubMedGoogle Scholar
  61. Matusan A E, Pryor M J, Davidson A D, Wright P J. 2001. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J Virol, 75: 9633–9643.PubMedCentralPubMedGoogle Scholar
  62. Miorin L, Romero-Brey I, Maiuri P, Hoppe S, Krijnse-Locker J, Bartenschlager R, Marcello A. 2013. Three-dimensional architecture of tick-borne encephalitis virus replication sites and trafficking of the replicated RNA. J Virol, 87: 6469–6481.PubMedCentralPubMedGoogle Scholar
  63. Murray C L, Jones C T, Rice C M. 2008. Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol, 6: 699–708.PubMedCentralPubMedGoogle Scholar
  64. Myong S, Bruno M M, Pyle A M, Ha T. 2007. Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase. Science, 317: 513–516.PubMedCentralPubMedGoogle Scholar
  65. Nall T A, Chappell K J, Stoermer M J, Fang N X, Tyndall J D, Young P R, Fairlie D P. 2004. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease. J Biol Chem, 279: 48535–48542.PubMedGoogle Scholar
  66. Niyomrattanakit P, Yahorava S, Mutule I, Mutulis F, Petrovska R, Prusis P, Katzenmeier G, Wikberg J E. 2006. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides. Biochem J, 397: 203–211.PubMedCentralPubMedGoogle Scholar
  67. Noble C G, Seh C C, Chao A T, Shi P Y. 2012. Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol, 86: 438–446.PubMedCentralPubMedGoogle Scholar
  68. Patkar C G, Kuhn R J. 2008. Yellow Fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol, 82: 3342–3352.PubMedCentralPubMedGoogle Scholar
  69. Paul D, Bartenschlager R. 2013. Architecture and biogenesis of plus-strand RNA virus replication factories. World J Virol, 2: 32–48.PubMedCentralPubMedGoogle Scholar
  70. Polacek C, Foley J E, Harris E. 2009. Conformational changes in the solution structure of the dengue virus 5′ end in the presence and absence of the 3′ untranslated region. J Virol, 83: 1161–1166.PubMedCentralPubMedGoogle Scholar
  71. Pyle A M. 2008. Translocation and unwinding mechanisms of RNA and DNA helicases. Annu Rev Biophys, 37: 317–336.PubMedGoogle Scholar
  72. Ramanathan M P, Chambers J A, Pankhong P, Chattergoon M, Attatippaholkun W, Dang K, Shah N, Weiner D B. 2006. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology, 345: 56–72.PubMedGoogle Scholar
  73. Rao S T, Rossmann M G. 1973. Comparison of super-secondary structures in proteins. J Mol Biol, 76: 241–256.PubMedGoogle Scholar
  74. Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, Deas T S, Zhou Y, Li H, Shi P Y. 2006. West Nile virus 5′-cap structure is formed by sequential guanine N-7 and ribose 2′-O methylations by nonstructural protein 5. J Virol, 80: 8362–8370.PubMedCentralPubMedGoogle Scholar
  75. Rendi-Wagner P. 2008. Advances in vaccination against tick-borne encephalitis. Expert Rev Vaccines, 7: 589–596.PubMedGoogle Scholar
  76. Robin G, Chappell K, Stoermer M J, Hu S H, Young P R, Fairlie D P, Martin J L. 2009. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation. J Mol Biol, 385: 1568–1577.PubMedGoogle Scholar
  77. Saalau-Bethell S M, Woodhead A J, Chessari G, Carr M G, Coyle J, Graham B, Hiscock S D, Murray C W, Pathuri P, Rich S J, Richardson C J, Williams P A, Jhoti H. 2012. Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function. Nat Chem Biol, 8: 920–925.PubMedCentralPubMedGoogle Scholar
  78. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel T A, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth N G, Lang J. 2012. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet, 380: 1559–1567.PubMedGoogle Scholar
  79. Salam K A, Akimitsu N. 2013. Hepatitis C virus NS3 inhibitors: current and future perspectives. Biomed Res Int, 2013: 467869.PubMedCentralPubMedGoogle Scholar
  80. Sampath A, Padmanabhan R. 2009. Molecular targets for flavivirus drug discovery. Antiviral Res, 81: 6–15.PubMedCentralPubMedGoogle Scholar
  81. Schiering N, D’Arcy A, Villard F, Simic O, Kamke M, Monnet G, Hassiepen U, Svergun D I, Pulfer R, Eder J, Raman P, Bodendorf U. 2011. A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target. Proc Natl Acad Sci USA, 108: 21052–21056.PubMedCentralPubMedGoogle Scholar
  82. Shadrick W R, Ndjomou J, Kolli R, Mukherjee S, Hanson A M, Frick D N. 2013. Discovering new medicines targeting helicases: challenges and recent progress. J Biomol Screen, 18: 761–781.PubMedGoogle Scholar
  83. Shiryaev S A, Kozlov I A, Ratnikov B I, Smith J W, Lebl M, Strongin A Y. 2007. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses. Biochem J, 401: 743–752.PubMedCentralPubMedGoogle Scholar
  84. Speroni S, De Colibus L, Mastrangelo E, Gould E, Coutard B, Forrester N L, Blanc S, Canard B, Mattevi A. 2008. Structure and biochemical analysis of Kokobera virus helicase. Proteins, 70: 1120–1123.PubMedGoogle Scholar
  85. Steimer L, Klostermeier D. 2012. RNA helicases in infection and disease. RNA Biol, 9.Google Scholar
  86. Story R M, Steitz T A. 1992. Structure of the recA protein-ADP complex. Nature, 355: 374–376.PubMedGoogle Scholar
  87. Suthar M S, Aguirre S, Fernandez-Sesma A. 2013. Innate immune sensing of flaviviruses. PLoS Pathog, 9: e1003541.PubMedCentralPubMedGoogle Scholar
  88. Tomei L, Failla C, Vitale R L, Bianchi E, De Francesco R. 1996. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J Gen Virol, 77: 1065–1070.PubMedGoogle Scholar
  89. Urbani A, Bazzo R, Nardi M C, Cicero D O, De Francesco R, Steinkuhler C, Barbato G. 1998. The metal binding site of the hepatitis C virus NS3 protease. A spectroscopic investigation. J Biol Chem, 273: 18760–18769.Google Scholar
  90. Verma R, Khanna P, Chawla S. 2013. Yellow fever vaccine: An effective vaccine for travelers. Hum Vaccin Immunother, 10: 126–128.Google Scholar
  91. Villordo S M, Gamarnik A V. 2009. Genome cyclization as strategy for flavivirus RNA replication. Virus Res, 139: 230–239.PubMedGoogle Scholar
  92. Welsch S, Miller S, Romero-Brey I, Merz A, Bleck C K, Walther P, Fuller S D, Antony C, Krijnse-Locker J, Bartenschlager R. 2009. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe, 5: 365–375.PubMedGoogle Scholar
  93. WHO. 2009. Fact sheet: Dengue and dengue haemorrhagic fever. http://www.who.int/csr/disease/dengue/en/ Google Scholar
  94. Wu J, Bera A K, Kuhn R J, Smith J L. 2005. Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J Virol, 79: 10268–10277.PubMedCentralPubMedGoogle Scholar
  95. Xu T, Sampath A, Chao A, Wen D, Nanao M, Chene P, Vasudevan S G, Lescar J. 2005. Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A. J Virol, 79: 10278–10288.PubMedCentralPubMedGoogle Scholar
  96. Xu T, Sampath A, Chao A, Wen D, Nanao M, Luo D, Chene P, Vasudevan S G, Lescar J. 2006. Towards the design of flavivirus helicase/NTPase inhibitors: crystallographic and mutagenesis studies of the dengue virus NS3 helicase catalytic domain. Novartis Found Symp, 277: 87–97; discussion 97–101, 251–103.PubMedGoogle Scholar
  97. Yamashita T, Unno H, Mori Y, Tani H, Moriishi K, Takamizawa A, Agoh M, Tsukihara T, Matsuura Y. 2008. Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A. Virology, 373: 426–436.PubMedGoogle Scholar
  98. Yao N, Reichert P, Taremi S S, Prosise W W, Weber P C. 1999. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure, 7: 1353–1363.PubMedGoogle Scholar
  99. Yon C, Teramoto T, Mueller N, Phelan J, Ganesh V K, Murthy K H, Padmanabhan R. 2005. Modulation of the nucleoside triphosphatase/RNA helicase and 5′-RNA triphosphatase activities of Dengue virus type 2 nonstructural protein 3 (NS3) by interaction with NS5, the RNA-dependent RNA polymerase. J Biol Chem, 280: 27412–27419.PubMedGoogle Scholar
  100. Yu I M, Zhang W, Holdaway H A, Li L, Kostyuchenko V A, Chipman P R, Kuhn R J, Rossmann M G, Chen J. 2008. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science, 319: 1834–1837.PubMedGoogle Scholar
  101. Yu L, Nomaguchi M, Padmanabhan R, Markoff L. 2008. Specific requirements for elements of the 5′ and 3′ terminal regions in flavivirus RNA synthesis and viral replication. Virology, 374: 170–185.PubMedCentralPubMedGoogle Scholar
  102. Yun S I, and Lee Y M. 2013. Japanese Encephalitis: The virus and vaccines. Hum Vaccin Immunother, 10.Google Scholar
  103. Yusof R, Clum S, Wetzel M, Murthy H M, Padmanabhan R. 2000. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem, 275: 9963–9969.PubMedGoogle Scholar
  104. Zhang L, Mohan P M, Padmanabhan R. 1992. Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5. J Virol, 66: 7549–7554.PubMedCentralPubMedGoogle Scholar
  105. Zhong B, Yang Y, Li S, Wang Y Y, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu H B. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity, 29: 538–550.PubMedGoogle Scholar
  106. Zou G, Chen Y L, Dong H, Lim C C, Yap L J, Yau Y H, Shochat S G, Lescar J, Shi P Y. 2011. Functional analysis of two cavities in flavivirus NS5 polymerase. J Biol Chem, 286: 14362–14372.PubMedCentralPubMedGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Lee Kong Chian School of MedicineNanyang Technological UniversitySingaporeRepublic of Singapore

Personalised recommendations